Senior insider sale
TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$2.11M
52.50K shares
What this filing means
BAYNES ROY D. plans to sell 52.50K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $2.11M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/1/2026ACC: 0001950047-26-003899
52.50K
Shares to sell
$2.11M
Approx. market value
9.75K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
5/1/2026
9.75KTotal acquired9.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/1/2026 | Stock Option Exercise Cash | 9.75K | — |
| Total | 9.75K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
32.75K
Market value
$1.35M
4/14/2026
—Completed
Units to sell
10K
Market value
$330.0K
4/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.75K
Market value
$431.1K
5/1/2026
Total
Units
52.50K
Value
$2.11M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/14/2026 | 32.75K | $1.35M | — | Completed |
4/6/2026 | 10K | $330.0K | — | Completed |
| Planned — Approximate Date | ||||
5/1/2026 | 9.75K | $431.1K | NASDAQ | Planned |
| Total | 52.50K | $2.11M | ||